
In the second part of a two-part interview, Paz Vellanki of Precision for Medicine explains which confirmatory evidence can support a single-trial approval and why she expects FDA's rare disease framework to last.
Glossary
over 23 years ago
The Basics of Chromatographyover 23 years ago
Choosing the Right Equipment for Process Chromatography






